Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide

Charles G. Zubrod, Marvin Schneiderman, Emil Frei, Clyde Brindley, G. Lennard Gold, Bruce Shnider, Raul Oviedo, John Gorman, Ralph Jones, Ulfar Jonsson, Jack Colsky, Thomas Chalmers, Bruce Ferguson, Margarida Dederick, James Holland, Oleg Selawry, William Regelson, Louis Lasagna, Albert H. Owens

Research output: Contribution to journalArticlepeer-review

925 Scopus citations

Abstract

Suggestions are made for the conduct of chemotherapy trials in patients with cancer. Application of the principles involved are illustrated in a comparative study of triethylene thiophosphoramide and nitrogen mustard in cancer of the lung and breast, melanoma, and Hodgkin's disease. Neither drug was appreciably effective in cancer of the lung which had previously been irradiated or in melanoma. In cancer of the lung not previously irradiated and in cancer of the breast, 30 to 50 per cent reduction in tumor size occurred in 10 to 26 per cent of the patients. In Hodgkin's disease certain factors limit the completeness of the comparison, but it is possible to draw the tentative conclusion that thio-TEPA was less active than HN2 (in the doses used) in inducing remissions. The advantages and disadvantages of this type of trial are discussed and several suggestions are made for improved experimental design.

Original languageEnglish
Pages (from-to)7-33
Number of pages27
JournalJournal of Chronic Diseases
Volume11
Issue number1
DOIs
StatePublished - Jan 1960
Externally publishedYes

Fingerprint

Dive into the research topics of 'Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide'. Together they form a unique fingerprint.

Cite this